T1	Treatment 100 132	imidafenacin versus fesoterodine
T2	Treatment 219 231	imidafenacin
T3	Treatment 237 249	fesoterodine
T4	Treatment 359 382	fesoterodine-controlled
T5	Treatment 561 598	twice-daily 0.1 mg imidafenacin with
T6	Treatment 611 645	once-daily 4 mg fesoterodine with
T7	Treatment 1468 1497	Imidafenacin was non-inferior
T8	Treatment 1686 1697	two groups.
T9	Treatment 1698 1739	CONCLUSIONS Imidafenacin was non-inferior
